Cellectis Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Nov 23 | BuyUS$80,000,000 | AstraZeneca PLC | Company | 16,000,000 | US$5.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,446,061 | 2.02% |
Private Companies | 2,509,157 | 3.5% |
VC/PE Firms | 5,873,247 | 8.19% |
Institutions | 13,514,380 | 18.8% |
Public Companies | 18,786,924 | 26.2% |
General Public | 29,621,432 | 41.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
16,000,000 | US$47.5m | 0% | no data | |||
5,873,247 | US$17.5m | 0% | 0.09% | |||
4,487,293 | US$13.3m | -37.4% | 1.42% | |||
2,786,924 | US$8.3m | 0% | no data | |||
2,609,801 | US$7.8m | 0% | no data | |||
2,175,218 | US$6.5m | 0.49% | no data | |||
1,743,678 | US$5.2m | 0% | no data | |||
1,438,255 | US$4.3m | 0% | no data | |||
1,039,906 | US$3.1m | 87.6% | 0.03% | |||
996,034 | US$3.0m | 0% | no data | |||
770,266 | US$2.3m | 6.91% | no data | |||
703,041 | US$2.1m | 0% | no data | |||
369,620 | US$1.1m | -34% | no data | |||
326,894 | US$971.3k | 100% | no data | |||
279,994 | US$831.9k | 0% | no data | |||
226,875 | US$674.1k | 0% | no data | |||
206,071 | US$612.3k | 0% | 0.03% | |||
183,011 | US$543.8k | 0% | no data | |||
133,143 | US$395.6k | 9.65% | no data | |||
126,342 | US$375.4k | 0% | 0.06% | |||
116,754 | US$346.9k | -12.8% | no data | |||
85,000 | US$252.5k | 0% | 0.02% | |||
76,225 | US$226.5k | 12.8% | no data | |||
72,187 | US$214.5k | 13.4% | no data | |||
71,638 | US$212.9k | 0% | no data |